Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company Deutsche Boerse AG

Equities

LLY

US5324571083

Market Closed - Deutsche Boerse AG
Other stock markets
 11:45:05 2024-05-31 EDT 		5-day change 1st Jan Change
754.7 EUR +0.12% Intraday chart for Eli Lilly and Company +1.41% +43.34%
05-30 Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs MT
05-30 Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs RE

Chart calendar Eli Lilly and Company

07d.4ks-LLzWSkpOvecduRQyV4owD6jvqJe9s-FTRu8cRbo.2noKe967LQIUhYNEgVNaZu5qXMSm-Obf0KowPJpLAOzaCWZmxYQnBijSqg~dd16373fce67d811c61fae667432cfff

Upcoming events on Eli Lilly and Company

Today 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 3150
Today 14:39 American Society of Clinical Oncology Meeting - Abstract Number: 8510
Today 16:00 American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
Today 16:12 American Society of Clinical Oncology Meeting - Abstract Number: 5001
2024-06-01 18:00 American Society of Clinical Oncology Meeting - Abstract Number: 3007
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 1027
2024-06-02 18:06 American Society of Clinical Oncology Meeting - Abstract Number: 10022
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 5589
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 11111
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 11068
2024-06-03 14:30 American Society of Clinical Oncology Meeting - Abstract Number: 8547
2024-06-03 18:12 American Society of Clinical Oncology Meeting - Abstract Number: LBA507
2024-06-10 16:00 Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-21 15:45 American Diabetes Association Scientific Symposium
2024-08-08 06:25 Q2 2024 Earnings Release

Past events on Eli Lilly and Company

2024-05-14 Ex-dividend day
2024-05-06 08:30 Annual General Meeting
2024-04-30 10:00 Q1 2024 Earnings Call
2024-04-30 06:45 Q1 2024 Earnings Release
2024-04-08 16:30 American Association for Cancer Research Meeting - Abstract Number: 3230
2024-04-08 16:30 American Association for Cancer Research Meeting - Abstract Number: 3316
2024-04-08 12:00 American Association for Cancer Research Meeting - Abstract Number: 1872
2024-03-09 American Academy of Dermatology Meeting
2024-03-06 09:10 TD Cowen Health Care Conference - Fireside Chat
2024-02-13 Ex-dividend day
2024-02-06 10:00 Q4 2023 Earnings Call
2024-02-06 06:45 Q4 2023 Earnings Release
2024-01-09 17:15 JPMorgan Healthcare Conference
2023-12-11 21:00 American Society of Hematology Meeting - Abstract No:5152
2023-12-11 20:00 American Society of Hematology Meeting - Abstract No:981
2023-12-10 21:00 American Society of Hematology Meeting - Abstract No:3269
2023-12-10 21:00 American Society of Hematology Meeting - Abstract No:3626
2023-12-10 21:00 American Society of Hematology Meeting - Abstract No:3026
2023-12-09 20:30 American Society of Hematology Meeting - Abstract No:1660
2023-12-09 20:30 American Society of Hematology Meeting - Abstract No:1737

Past dividends on Eli Lilly and Company

2024-05-14 Quarterly 1.3 USD
2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
42 980

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 283

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 705

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
13 737

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 932

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%
10 001


11 322


12 785


10 920


12 135

EBITDA
Million USD		Released
Forecast
Spread 		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%
3 750


4 841


5 997







EBIT
Million USD		Released
Forecast
Spread 		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%
3 077


3 973


4 811







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%
3 000


3 878


4 497







Net income
Million USD		Released
Forecast
Spread 		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%
2 477


3 249


4 025







EPS
USD		Released
Forecast
Spread


1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%
2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Upcoming sector events for Eli Lilly and Company

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected)
2024-07-15 JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected)
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
2024-05-29 04:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-29 04:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 PFIZER LIMITED: Q4 2024 Earnings Release
2024-05-27 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
2024-05-27 08:10 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Calendar Eli Lilly and Company